Atarax is a brand-name medication that contains the antihistamine hydroxyzine as its active ingredient. Hydroxyzine belongs to the p-block antihistamine class and is used in Hong Kong under prescription control. The medication is supplied as a pill (tablet) in 10 mg and 25 mg strengths. It is marketed for two primary therapeutic areas: mental health (especially anxiety and sedation) and allergy relief (such as itching and urticaria). Regulatory approval for these uses is overseen by the Hong Kong Department of Health and aligns with international standards set by agencies such as the FDA and EMA.
Hydroxyzine blocks the action of histamine at H1 receptors throughout the body. By preventing histamine from binding, the drug reduces the typical allergic response that causes itching, redness, and swelling. In the central nervous system, hydroxyzine also exerts a sedative effect through antagonism of central H1 receptors and modest anticholinergic activity. This dual action explains why Atarax can calm anxiety and also relieve allergic skin symptoms.
Hydroxyzine is well-absorbed from the gastrointestinal tract, reaching peak blood levels without the need for food. It is metabolized primarily by the CYP3A4 enzyme system and eliminated via the kidneys.
Atarax is approved in Hong Kong for the following indications:
These uses reflect the drug’s ability to calm the central nervous system while simultaneously addressing histamine-mediated skin reactions. The medication is typically prescribed for adult patients; pediatric use is limited to specific circumstances and only under specialist supervision.
Hydroxyzine has been explored in clinical studies for several off-label applications. While not approved by the Hong Kong Department of Health for these purposes, the evidence is noteworthy:
Off-label use requires medical supervision and individualized risk assessment. Physicians must weigh the limited evidence against potential side-effects before prescribing hydroxyzine for these conditions.
If any of the following occur-rapid heartbeat, chest pain, fainting, or persistent vomiting-seek urgent medical attention.
Patients should inform their healthcare provider of all prescription medicines, over-the-counter products, supplements, and herbal preparations before starting Atarax.
Standard adult dosing:
Anxiety: 25 mg taken orally 3-4 times daily, not to exceed 100 mg per day.
Itching: 25 mg taken 2-3 times daily; a 10 mg dose may be used for milder symptoms.
Initiation: Start with the lowest effective dose (often 10 mg) to assess tolerance, then titrate up as needed.
Special populations:
Elderly: Begin with 10 mg once or twice daily; increase cautiously.
Renal impairment (CrCl < 30 mL/min): Reduce dose by 50 % and monitor sedation.
Hepatic impairment: Use the lowest effective dose and avoid rapid dose escalation.
Administration: Swallow tablets whole with a glass of water. Do not crush or chew, as this may alter absorption.
Missed dose: Take the missed dose as soon as remembered unless it is almost time for the next scheduled dose. Do not double the dose.
Overdose: Symptoms may include extreme drowsiness, rapid heart rate, nausea, and low blood pressure. Seek emergency medical care; supportive care and monitoring are the mainstays of treatment. No specific antidote exists.
Discontinuation: Hydroxyzine does not typically require tapering, but abrupt cessation after prolonged high-dose use may cause rebound anxiety or insomnia. Discuss any planned stop-dates with a prescriber.
Regular follow-up appointments enable dose adjustments and early detection of adverse effects.
This article provides educational information about Atarax and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
Hydroxyzine does not directly affect blood pressure, but it can cause mild sedation that may worsen the dizziness sometimes associated with certain antihypertensives. Discuss any combination with your prescribing clinician to ensure safe monitoring.
Hydroxyzine is not a controlled substance and is generally not screened for in standard drug-testing panels. However, some athletic agencies may test for antihistamines if they suspect performance-enhancing effects; always verify the specific testing protocol of your organization.
In Hong Kong, 10 mg tablets are typically imprinted with “AT 10” and 25 mg tablets with “AT 25.” Imprint designs can vary by manufacturer, so compare the physical description with the packaging insert.
Yes, provided you carry the medication in its original labeled container, accompanied by a copy of the prescription and a doctor’s note if required by customs. Keep the tablets in your carry-on luggage to avoid temperature extremes.
Hydroxyzine is classified as Category D, indicating potential fetal risk throughout pregnancy. Use is only justified if the therapeutic benefit outweighs the risk and after thorough discussion with an obstetrician.
For most adults, the calming effect peaks around 2 hours after ingestion and typically diminishes after 4-6 hours. Individual metabolism and dosage can modify this timeframe.
Food may slightly delay the onset of action but does not substantially change overall absorption. Taking the pill with a glass of water, with or without meals, is acceptable.
Yes, hydroxyzine is marketed under several generic names in Hong Kong. While Atarax is a well-known brand, the active ingredient is identical across generic formulations.
Increase fluid intake, chew sugar-free gum, or use saliva substitutes. If dry mouth persists or interferes with daily activities, contact your healthcare provider for possible dose adjustment.
Combining two antihistamines can amplify anticholinergic side effects such as dry mouth and constipation. It is generally discouraged unless specifically advised by a physician.
